OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push

Following the release of its second-quarter financial results, OptimizerRx Corp OPRX stock witnessed a 22.66% surge during after-hours trading on Thursday.

Check out the current price of OPRX stock here

What Happened: The Michigan-based digital health company’s stock soared to $15.75 per share in extended trading. This increase came after the company’s shares closed at $12.84, which was up 2.88% earlier in the regular session, according to Benzinga Pro data.

OptimizerRx’s second-quarter earnings outperformed market expectations, with a $0.22 beat and revenue of $29.2 million surpassing estimates of $22.6 million.

See Also: Brazil’s President Says ‘Won’t Humiliate Myself’ By Calling Trump — Seeks Joint BRICS Response With China, India To Counter Tariffs

"Our year-to-date results continue to deliver profitable growth ahead of expectations. Contracted revenue is now up more than 30% year-over-year, positioning us for a strong finish to the second half," stated Stephen L. Silvestro, CEO of OptimizeRx. 

The healthcare communication company has traded between $3.78 and $15.71 over the past 52 weeks. With a market capitalization of $237.48 million, OptimizeRx has a trading volume of 419,818 shares, above its average volume of 296,769.

Why It Matters: OptimizeRx’s second-quarter financial results have been impressive, with a 55% year-over-year increase in revenue to $29.2 million. Gross profit also saw a 59% year-over-year rise to $18.6 million. The company’s Generally Accepted Accounting Principles net income for the second quarter was $1.5 million, a significant improvement from the GAAP net loss of $4.0 million in the same period last year, as reported by OptimizerRx.

Following this strong performance, OptimizerRx has raised its full-year 2025 guidance, now expecting a revenue range between $104 million and $108 million and an adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) range between $14.5 million and $17.5 million.

As a result, the company’s shares are trading higher, reflecting investor confidence in its growth trajectory and financial performance.

With a strong Momentum in the 94th percentile, Benzinga’s Edge Stock Rankings indicate that OPRX is experiencing short-term consolidation along with medium and long-term upward movement. Know how its momentum lines up with other well-known names.

Loading...
Loading...

Read Next:

Photo Courtesy: Mizkit on Shutterstock.com

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

OPRX Logo
OPRXOptimizeRx Corp
$17.4535.9%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
94.62
Growth
19.68
Quality
N/A
Value
2.88
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...